SOURCE: Syneron Medical Ltd.

Syneron Medical Ltd.

July 06, 2010 10:25 ET

Syneron's eMatrix™ Addresses Global Demand for Treating All Skin Tones

Sublative Rejuvenation™ Expands the Capabilities of Energy-Based Facial Rejuvenation

YOKNEAM, ISRAEL and IRVINE, CA--(Marketwire - July 6, 2010) - Syneron Medical Ltd. (NASDAQ: ELOS), http://www.syneron.com, a leading medical aesthetic device innovator, reports today the growing popularity of eMatrix™ amongst physicians worldwide in safely and effectively treating all skin tones. Historically, physicians have struggled to find treatments that could deliver significant noticeable results for all skin tones while remaining gentle enough to prevent adverse events. The most common dermatological concerns for patients with darker skin tones, which include African-American, Asian, Hispanic, East Indian and other darker skin type patients, are scarring and discoloration.

Dr. Doris Day, an author and a board certified dermatologist at Day Dermatology and Aesthetics in Manhattan, New York, recently appeared on The View (http://www.youtube.com/watch?v=yoNoqOofUPY) to demonstrate the latest aesthetic breakthroughs that address the common concerns of her patients with ethnic skin tones. Dr. Day noted, "It's important to use treatments that are designed with skin of color in mind, otherwise there is a risk of increased scarring and discoloration after the treatment." According to Dr. Day, Sublative Rejuvenation with eMatrix is opening up a whole new world of safe and efficacious treatments for patients with darker skin who previously had limited options.

Sublative Rejuvenation, an entirely new treatment category in energy-based facial rejuvenation, uses fractionated bi-polar radio frequency (RF) energy to place the maximum amount of heat into the dermal layer of the skin with minimal disruption of the epidermal layer of the skin intact. "The innovative method of energy delivery is what truly sets Sublative Rejuvenation apart from all the other energy-based facial rejuvenation treatments," said Dr. Michael Gold, a board certified dermatologist at the Gold Skin Care Center in Nashville, Tennessee. "Now I can effectively treat challenging skin irregularities like acne scars, and for the first time have the freedom to safely treat my darker skin patients."

Sublative Rejuvenation with eMatrix is anticipated to be a one of the leading topics at the upcoming IMCAS Asia conference, held in Hong Kong, China in July. "Over the years, we've witnessed a number of technologies that attempted to achieve the same effective and reproducible results for ethnic skin patients as seen on lighter skin patients," said Dr. Henry Chan, a dermatologist in Hong Kong, China. "My clinical findings of Sublative Rejuvenation with eMatrix, which I will present at IMCAS Asia, shows that it is truly one of the few devices to safely and successfully induce skin rejuvenation, especially acne scarring amongst my skin of color patients. It is quite remarkable and I'm excited to see the expanded capabilities of Sublative Rejuvenation beyond our current knowledge of this novel treatment."

Attendees at the 2010 IMCAS Asia conference (www.imcas.com) can obtain a demonstration and preview of multiple product offerings at the Syneron and Candela booth #EO1.

About the eMatrix™
The eMatrix™ system with Syneron's unique Sublative Rejuvenation treatment is the newest innovation in energy-based facial rejuvenation. The system utilizes fractionated bi-polar radio frequency (RF) technology -- to place the heat energy effectively into the dermis where it can produce significant dermal impact with minimal epidermal disruption. The eMatrix™ offers an industry breakthrough intelligent feedback system that gives real time feedback of skin condition (impedance) and actual energy delivered. The addition of the evolutionary Sublative RF High Density tip, which exemplifies eMatrix' continued commitment to scientific advances, displays the true versatility and advancement of the system, addressing multiple conditions from one system. The treatments offer high dermal remodeling -- low downtime -- high clinical result -- high patient satisfaction.

To learn more about the eMatrix™ Sublative Rejuvenation device, including the latest clinical data and before and after photos, visit www.syneron.com.

About Syneron Medical Ltd.
Syneron Medical Ltd. -- a company devoted to real technology, real science and real results -- is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Additional information can be found at www.syneron.com.